MIR373 is a microRNA implicated in various cellular processes, including the regulation of the actin cytoskeleton, as suggested by computational algorithms that predict its role in modulating proteins such as twinfilin and profilin-2 [PMC7408560]. Research has shown that inhibiting microRNAs like MIR373 can lead to the de-repression of their target genes, indicating a regulatory function [PMC6591970]. In the context of breast cancer, MIR373 has been identified as a potential biomarker; its expression levels were notably different when comparing breast cancer patients to healthy individuals [PMC8182592]. Furthermore, MIR373 has been associated with metastatic ability in cancer studies, where it is found in a subpopulation of cells with extensive chromosomal aberrations [PMC8466266]. In terms of diagnostic potential, MIR373 was evaluated alongside other microRNAs such as miR371 and miR372; however, miR371 was found to have superior sensitivity and specificity for certain conditions [PMC8575592]. Lastly, increased levels of MIR373 have been observed in the substantia nigra (SN) of patients with Parkinson's disease (PD), suggesting its involvement in defective chaperone-mediated autophagy (CMA) and potential accumulation and aggregation of pathological proteins like α-synuclein [PMC6627933].
- G uuuuug gggauACUC AAAAU GGGGCGCUUUCC u ||||||||| ||||| |||||||||||| cccUGUGGG UUUUA CUUCGUGAAGgg c G G ucaugu
Name | Accession | Chromosome | Start | End | Strand | Confidence |
---|
Disease | Description | Category | PubMed ID |
---|
Accession | MIMAT0000725 |
Description | Homo sapiens hsa-miR-373-5p mature miRNA |
Sequence | 6 - ACUCAAAAUGGGGGCGCUUUCC - 27 |
Evidence |
experimental
cloned [1] |
Accession | MIMAT0000726 |
Description | Homo sapiens hsa-miR-373-3p mature miRNA |
Sequence | 44 - GAAGUGCUUCGAUUUUGGGGUGU - 66 |
Evidence |
experimental
cloned [1-2], Northern [1] |
Database links |
![]() ![]() ![]() |
Predicted targets |
![]() ![]() ![]() |
|